Home › Hypertrophic Cardiomyopathy › Pennsylvania
Hypertrophic Cardiomyopathy clinical trials in Pennsylvania
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Pennsylvania.
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's University Health Network, Bethlehem
- University Of Pittsburgh, Pittsburgh
- Geisinger Health System, Wilkes-Barre
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Philadelphia
- Imbria Investigational Site, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 8 and older · Men · Updated May 4, 2026 · NCT06092034From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.